Ktias
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Erviknesveien 85, Bjugn, Sor-Trondelag, ...Phone Number
+47 90239166Revenue
<$5 MillionIndustry
ZI Rank: 1
About Ktias
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ktias your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Ktias has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Ktias had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Ktias, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ktias has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ktias launches new products
Earning: See what the market has to say on Ktias recently announced quarterly report
Check out if Ktias is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Ktias
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ktias is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ktias is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ktias.
Ktias Tech Stack
A closer look at the technologies used by Ktias
Top Business Services Companies
Frequently Asked Questions Regarding Ktias
KTIAS is focused on developing a medical project aimed at treating chronic neuropathy caused by platinum-containing chemotherapeutics. The treatment method is protected by patents in the USA, Europe, China, and Japan. The company is actively seeking a partner to advance this project towards becoming an approved drug. Their target clients include ph... Read More
